The Harm Reduction Promise of GLP-1s

The Harm Reduction Promise of GLP-1s

0 Umsagnir
0
Episode
2121 of 2199
Lengd
1Klst. 31Mín.
Tungumál
enska
Gerð
Flokkur
Óskáldað efni

Could GLP-1s become the next frontier in harm reduction? Clinical researchers have discovered that GLP‑1 drugs like Ozempic and Wegovy not only aid with diabetes and weight loss but may also reduce cravings and enhance satiation for alcohol, tobacco, cannabis, opioids, and possibly other addictive drugs like cocaine and methamphetamine. These exciting developments mean GLP-1s may soon become a new harm-reduction tool and possibly transform the treatment of substance use disorders. Our expert panel will explore the latest findings, their transformative implications for addiction treatment, and policies to improve affordability and access for those who need them. Hosted on Acast. See acast.com/privacy for more information.


Hlustaðu og lestu

Stígðu inn í heim af óteljandi sögum

  • Lestu og hlustaðu eins mikið og þú vilt
  • Þúsundir titla
  • Getur sagt upp hvenær sem er
  • Engin skuldbinding
Prófa frítt
is Device Banner Block 894x1036
Cover for The Harm Reduction Promise of GLP-1s

Other podcasts you might like ...